S E Berning, M D Iseman. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » AdultAgedAnti-Bacterial Agents/adverse effectsAntibiotics, Antitubercular/adverse effectsAntibodies, Antinuclear/analysisDrug InteractionsFemaleHumansLupus Erythematosus, Systemic/chemically inducedLupus Erythematosus, Systemic/immunologyMaleMiddle AgedMycobacterium Infections/drug therapyRifabutin/adverse effectsRifamycins/adverse effectsSyndrome
Substances： See more » Anti-Bacterial AgentsAntibiotics, AntitubercularAntibodies, AntinuclearRifamycinsRifabutin
Year: 1997 PMID： 9167470 DOI： 10.1016/S0140-6736(05)62102-2
Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321